Iris Kleerekooper
Overview
Explore the profile of Iris Kleerekooper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kleerekooper I, Wagner S, Trip S, Plant G, Petzold A, Keane P, et al.
Br J Ophthalmol
. 2023 Jun;
108(5):695-701.
PMID: 37385651
Background/aims: The analysis of visual field loss patterns is clinically useful to guide differential diagnosis of visual pathway pathology. This study investigates whether a novel index of macular atrophy patterns...
2.
Kleerekooper I, Chua S, Foster P, Trip S, Plant G, Petzold A, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e220902.
PMID: 35238934
Importance: Understanding the effects of modifiable risk factors on risk for multiple sclerosis (MS) and associated neurodegeneration is important to guide clinical counseling. Objective: To investigate associations of alcohol use,...
3.
Kleerekooper I, Houston S, Dubis A, Trip S, Petzold A
Front Neurol
. 2020 Dec;
11:604049.
PMID: 33362705
Vascular changes are increasingly recognized as important factors in the pathophysiology of neuroinflammatory disease, especially in multiple sclerosis (MS). The relatively novel technology of optical coherence tomography angiography (OCTA) images...
4.
Kleerekooper I, Trip S, Plant G, Petzold A
J Neurol Neurosurg Psychiatry
. 2020 Nov;
92(3):340-342.
PMID: 33148814
No abstract available.
5.
Marshall J, Kleerekooper I, Davagnanam I, Trip S
Mult Scler
. 2020 Apr;
26(14):1958-1960.
PMID: 32228206
The cardinal features of neuromyelitis optica spectrum disorder (NMOSD) are optic neuritis, longitudinal extensive transverse myelitis and area postrema syndrome. Olfactory dysfunction is not listed as a feature in the...
6.
Kleerekooper I, Herbert M, Kuiperij H, Sato D, Fujihara K, Callegaro D, et al.
J Neurol Neurosurg Psychiatry
. 2020 Mar;
91(6):605-611.
PMID: 32217788
Objective: To explore levels of astrocytopathy in neuromyelitis optica spectrum disorder (NMOSD) by measuring levels of the astrocytic enzyme glutamine synthetase (GS) and glial fibrillary acidic protein (GFAP), an established...
7.
Kleerekooper I, Petzold A, Trip S
Brain
. 2020 Mar;
143(7):1999-2008.
PMID: 32163545
Mitochondrial failure and hypoxia are key contributors to multiple sclerosis pathophysiology. Importantly, improving mitochondrial function holds promise as a new therapeutic strategy in multiple sclerosis. Currently, studying mitochondrial changes in...
8.
Wijburg M, Kleerekooper I, Lissenberg-Witte B, de Vos M, Warnke C, Uitdehaag B, et al.
JAMA Neurol
. 2018 Mar;
75(7):827-833.
PMID: 29532061
Importance: The JC virus (JCV) was named after the first patient to be described with progressive multifocal leukoencephalopathy (PML), John Cunningham. Detection of JC virus DNA in cerebrospinal fluid (CSF)...
9.
Kleerekooper I, van Kempen Z, Leurs C, Dekker I, Rispens T, Lissenberg-Witte B, et al.
Neurol Neuroimmunol Neuroinflamm
. 2018 Jan;
5(1):e424.
PMID: 29379823
Objective: To investigate disease activity and disability progression following pregnancy-related discontinuation of natalizumab (NTZ) in patients with relapsing-remitting MS. Methods: A retrospective cohort study of clinical and radiologic data in...
10.
Kleerekooper I, van Rooij S, van den Wildenberg W, de Leeuw M, Kahn R, Vink M
Neuroimage
. 2016 Feb;
132:51-58.
PMID: 26899783
Inhibitory control, like most cognitive processes, is subject to an age-related decline. The effect of age on neurofunctional inhibition processing remains uncertain, with age-related increases as well as decreases in...